Bluepharma: From the generic drugs for the advanced therapies

The Portuguese company began by launching generic medicines that were almost unavailable, and today it is also dedicated to advanced, complex, and innovative therapies.
In 20 years, Bluepharma has created 20 companies and supplies some of the biggest multinationals in the pharmaceutical sector, exporting to more than 40 countries.

Including the United States, where it intends to grow in the coming years. Bluepharma exports around 87 percent of its production, mostly to its main markets in France and Germany.

However, the company's global expansion extends beyond Europe to countries such as Australia, the United States, the Middle East, Africa, and Latin America.